An extensive revision of US childhood vaccination guidelines has resulted in a reduction in the quantity of universally recommended vaccines from 17 to 11.
The newly issued list from the Centers for Disease Control and Prevention includes essential vaccines for diseases like poliomyelitis and rubeola. However, several others, including hepatitis A and B and coronavirus vaccines, are now categorized based on individual risk and subject to "joint clinical deliberation" involving doctors and parents.
"This new recommendation is risky and unnecessary," criticized the AAP, labeling the change.
This far-reaching policy change represents the most recent major move undertaken under the current administration by Health Secretary Robert F. Kennedy Jr.
Government Rationale and Global Alignment
Kennedy claimed the revision came "following an exhaustive analysis" and "protects children, respects families, and restores trust in the health system."
"We are aligning the U.S. childhood vaccine calendar with international standards while enhancing openness and parental choice," he continued.
According to the announcement, the updated core recommendation for all minors will cover immunizations for:
- MMR (Measles, Mumps, Rubella)
- Polio
- DTaP/Tdap (Diphtheria, Tetanus, Pertussis)
- Haemophilus influenzae type b (Hib)
- Pneumococcus infection
- HPV
- Varicella (chickenpox)
3 Categories of Recommendations
The new framework creates three distinct categories of vaccine guidance:
- Core Vaccines: The 11 immunizations listed above are advised for every youngsters.
- Risk-Based Vaccines: This category includes vaccines for respiratory syncytial virus, hepatitis A, Hep B, dengue, and meningococcal types (ACWY and B). They are recommended based on a patient's specific health circumstances.
- Optional Group: Immunizations for Covid-19, the flu, and rotavirus are now left to case-by-case discussion and decision by families and their doctors.
For the time being, medical coverage will still cover vaccines that are currently on the schedule until the close of 2025.
International Perspective and Recent Debate
The health agency performed a comparison of current pediatric recommendations with those of 20 other industrialized nations. It found the US was "an international exception" in both the number of diseases targeted and the amount of doses required, the HHS said.
This recent announcement comes a short time following a different advisory panel modified the schedule for the initial hepatitis B shot. Formerly, a first dose was recommended for infants within 24 hours of birth. Updated rules last winter moved that to 60 days post birth if the parent tested non-reactive for hepatitis B.
That earlier change was widely condemned by paediatricians, with the American Academy of Pediatrics calling it "a risky step that will harm children."
